Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fortunato Morabito

Showing results (121-130 of 302) with videos related to

Pageof 31
Sort By:
European Journal of Haematology|October 29, 2025
Clinical Utility of Frailty Scoring in Elderly Acute Myeloid Leukemia Patients Treated With Venetoclax and Hypomethylating AgentsErnesto Vigna, Antonella Bruzzese, Enrica Antonia Martino, et al.
JCO Global Oncology|October 31, 2024
Survival Risk Score for Invasive Nonmetastatic Breast Cancer: A Real-World AnalysisLucia Mangone, Fortunato Morabito, Giovanni Tripepi, et al.
European Journal of Haematology|March 6, 2025
Therapeutic Strategies for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia in Adult Patients: Optimizing the Use of Monoclonal AntibodiesAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
Haematologica|January 19, 2007
Integrative genomic analysis reveals distinct transcriptional and genetic features associated with chromosome 13 deletion in multiple myelomaLuca Agnelli, Silvio Bicciato, Sonia Fabris, et al.
British Journal of Haematology|May 10, 2007
MDR1 polymorphism influences the outcome of multiple myeloma patientsGabriele Buda, Valentina Maggini, Sara Galimberti, et al.
Expert Opinion on Pharmacotherapy|April 16, 2024
Momelotinib in myelofibrosisAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
Expert Opinion on Pharmacotherapy|September 24, 2013
An old drug with a new future: bendamustine in multiple myelomaMassimo Gentile, Anna Grazia Recchia, Carla Mazzone, et al.
Blood|April 22, 2008
CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome?Semra Aydin, Davide Rossi, Luciana Bergui, et al.
Leukemia Research|October 27, 2005
Different gamma/delta T clones sustain GVM and GVH effects in multiple myeloma patients after non-myeloablative transplantationSara Galimberti, Edoardo Benedetti, Fortunato Morabito, et al.
Expert Opinion on Investigational Drugs|October 4, 2017
Venetoclax for the treatment of chronic lymphocytic leukemiaMassimo Gentile, Annamaria Petrungaro, Giuseppina Uccello, et al.
Pageof 31

Showing results (121-130 of 302) with videos related to

Sort By:
Pageof 31
European Journal of Haematology|October 29, 2025
Clinical Utility of Frailty Scoring in Elderly Acute Myeloid Leukemia Patients Treated With Venetoclax and Hypomethylating AgentsErnesto Vigna, Antonella Bruzzese, Enrica Antonia Martino, et al.
JCO Global Oncology|October 31, 2024
Survival Risk Score for Invasive Nonmetastatic Breast Cancer: A Real-World AnalysisLucia Mangone, Fortunato Morabito, Giovanni Tripepi, et al.
European Journal of Haematology|March 6, 2025
Therapeutic Strategies for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia in Adult Patients: Optimizing the Use of Monoclonal AntibodiesAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
Haematologica|January 19, 2007
Integrative genomic analysis reveals distinct transcriptional and genetic features associated with chromosome 13 deletion in multiple myelomaLuca Agnelli, Silvio Bicciato, Sonia Fabris, et al.
British Journal of Haematology|May 10, 2007
MDR1 polymorphism influences the outcome of multiple myeloma patientsGabriele Buda, Valentina Maggini, Sara Galimberti, et al.
Expert Opinion on Pharmacotherapy|April 16, 2024
Momelotinib in myelofibrosisAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
Expert Opinion on Pharmacotherapy|September 24, 2013
An old drug with a new future: bendamustine in multiple myelomaMassimo Gentile, Anna Grazia Recchia, Carla Mazzone, et al.
Blood|April 22, 2008
CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome?Semra Aydin, Davide Rossi, Luciana Bergui, et al.
Leukemia Research|October 27, 2005
Different gamma/delta T clones sustain GVM and GVH effects in multiple myeloma patients after non-myeloablative transplantationSara Galimberti, Edoardo Benedetti, Fortunato Morabito, et al.
Expert Opinion on Investigational Drugs|October 4, 2017
Venetoclax for the treatment of chronic lymphocytic leukemiaMassimo Gentile, Annamaria Petrungaro, Giuseppina Uccello, et al.
Pageof 31